Age 40 Years and Under Does Not Confer Superior Prognosis in Patients with Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transmplant
Author:
Publisher
Elsevier BV
Subject
Transplantation,Hematology
Reference54 articles.
1. Long term survival in multiple myeloma;Kyle;N Engl J Med,1983
2. Review of 1072 patients with newly diagnosed multiple myeloma;Kyle;Mayo Clin Proc,2003
3. Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years;Blade;Br J Haematol,1996
4. Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group;Ludwig;Blood,2008
5. Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age;Mileshkin;Blood,2003
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiple Myeloma in Young Patients: A Scoping Review;Clinical Lymphoma Myeloma and Leukemia;2024-01
2. Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant;British Journal of Haematology;2023-06-27
3. Multiple Myeloma in a Young Adult with Renal Involvement;Clinical Case Reports;2023-02
4. Clinical profiles and outcomes of young versus elderly patients with multiple myeloma: A retrospective observational study from a tertiary cancer center in South India;Cancer Research, Statistics, and Treatment;2023
5. Young multiple myeloma – An unexplored territory?;Cancer Research, Statistics, and Treatment;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3